Pavan Anne
@db_pavan
Precision Medicine Enthusiast. Cricket Lover and Chelsea FC Fanatic.
You might like
ZS's innovative digital solution for rare disease diagnosis has been recognized as a finalist in the Fierce Life Sciences Innovation Awards. #DigitalHealth #FierceInnovation #RareDiseaseCare bit.ly/47uxgHm
AI, data and diagnostics are transforming precision medicine. Explore how next-generation Rx-Dx partnerships are evolving from single-test collaborations to shared ecosystems built on trust, flexibility and innovation. bit.ly/48JHCFD
ZS named a Leader in IDC MarketScape analyst report for HCP engagement
Emerging biopharma first launches held steady in the U.S. in 2024, while the EU saw just one. Our analysis explores the commercialization paths, launch performance and future trajectories of novel first launchers. We also examine what happens postlaunch—how many scale, stall...
🗺️ Map out your onsite adventure at Dreamforce 2025 and learn how ZS is redefining what CRMs can do. See how to leverage tech and AI to climb faster and scale smarter to create better customer experiences. bit.ly/4gxR6Wk #DF25 #SafesforcePartner #CRM
Salesforce unveils life sciences partner network to accelerate digital labor and data programs
Balancing personal and nonpersonal resources isn’t easy for medical affairs organizations—but our action plan can help. Download the white paper: bit.ly/3Fg4yzM #Pharma #MedicalAffairs
ZS Discovery’s Claus Lundegaard and Milena Vujovic explore how epitope-focused cancer vaccines and in-silico methods could have the power to transform cancer immunology. Read the full story: bit.ly/4kSwXfp #ZSDiscovery #Oncology #Vaccines
ZS and NCODA are proud to share that the 2024 NCODA Oncology Institute - Delivering Equitable Care through Partnership with Industry and the Oncology Community has received a PM360 PharmaChoice Silver Award in the Multicultural category. This award, voted on by industry peers,...
Searching for value in your AI projects? ZS lights your path during Impact Live Boston 2025. bit.ly/4iSyy3z #ZSImpactLive #AIinPharma #HealthcareAI bit.ly/42hdSes
ZS has been named one of Forbes America's Best Management Consulting Firms 2025—our 10th year in a row! I am grateful to be part of a team that’s consistently raising the bar to improve life and how we live it. #lifeatZS #ForbesBest bit.ly/3RBzkWq
I sat down with Dr. Charles Powell, CEO, Mount Sinai Respiratory Institute and Dr. Omar Perez, Head of Medical Diagnostics at AstraZeneca, to discuss a major challenge: Lung cancer screening remains underutilized with only handful patients being screened. bit.ly/4bkAvCO
The US oncology biosimilar market has grown rapidly since 2017, driven by price discounts, payer adoption and provider confidence. Stay ahead of the curve—explore the potential of upcoming biosimilars for growth and savings. Learn more. bit.ly/4g7Oc9a
How does market competition lead to better patient outcomes? In this white paper, we track the impact that having more players in an indication can mean for higher diagnosis rates in rare diseases: bit.ly/4hv4hqo
Our new report includes findings across seven countries and recommendations for navigating the future of health. Download it now: bit.ly/3PAe9mJ #FutureOfHealth #ZSFOHReport bit.ly/4fYgGBW
United States Trends
- 1. #HardRockBet 1,435 posts
- 2. #AskFFT N/A
- 3. Mason Rudolph 2,281 posts
- 4. Klay 39.4K posts
- 5. Aaron Rodgers 5,194 posts
- 6. Good Sunday 82.2K posts
- 7. Emanuel Wilson N/A
- 8. Full PPR 1,262 posts
- 9. Raora 4,046 posts
- 10. Josh Jacobs 1,698 posts
- 11. #sundayvibes 7,255 posts
- 12. Ja Morant 18.2K posts
- 13. Great for 60 N/A
- 14. Sean Tucker N/A
- 15. Cornbread 1,867 posts
- 16. #AskBetr N/A
- 17. Arsenal 214K posts
- 18. NFL Sunday 6,989 posts
- 19. Tottenham 65.3K posts
- 20. Judkins 1,359 posts
You might like
Something went wrong.
Something went wrong.